MiNK Therapeutics Announces Appointment of Dr. Robert Kadlec to Board[...]
Arrow Reports 3rd Quarter Net Income of $9.0 Million, or $0.53 per Share
10/31/2024 | Press release | Distributed by Public on 10/31/2024 07:24
Please select the service you want to use:
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact